chr16-763260-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005823.6(MSLN):c.113C>T(p.Ala38Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000879 in 1,542,576 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005823.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSLN | NM_005823.6 | c.113C>T | p.Ala38Val | missense_variant | 4/18 | ENST00000545450.7 | NP_005814.2 | |
MSLN | NM_013404.4 | c.113C>T | p.Ala38Val | missense_variant | 3/17 | NP_037536.2 | ||
MSLN | NM_001177355.3 | c.113C>T | p.Ala38Val | missense_variant | 4/18 | NP_001170826.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSLN | ENST00000545450.7 | c.113C>T | p.Ala38Val | missense_variant | 4/18 | 1 | NM_005823.6 | ENSP00000442965.2 |
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 152114Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000458 AC: 68AN: 148618Hom.: 1 AF XY: 0.000424 AC XY: 34AN XY: 80116
GnomAD4 exome AF: 0.000919 AC: 1278AN: 1390344Hom.: 1 Cov.: 31 AF XY: 0.000917 AC XY: 630AN XY: 686858
GnomAD4 genome AF: 0.000512 AC: 78AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2024 | The c.113C>T (p.A38V) alteration is located in exon 3 (coding exon 2) of the MSLN gene. This alteration results from a C to T substitution at nucleotide position 113, causing the alanine (A) at amino acid position 38 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at